FDA declines to approve Intellipharma's opioid painkiller

(Reuters) – Intellipharmaceutics International Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve its long-acting opioid painkiller in its current form, backing its independent advisory panel that had raised concerns over the drug’s abuse-deterrence capabilities.


Source: Reuters Health News